microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity

被引：0
|
作者：
Elizabeth C Martin
Lyndsay V Rhodes
Steven Elliott
Adrienne E Krebs
Kenneth P Nephew
Erik K Flemington
Bridgette M Collins-Burow
Matthew E Burow
机构：
[1] Tulane University,Department of Medicine
[2] Tulane University,Section of Hematology and Medical Oncology
[3] Tulane University,Department of Pharmacology
[4] Tulane University,The Center for Bioenvironmental Research
[5] Indiana University School of Medicine,Department of Pathology
来源：
Molecular Cancer | / 13卷
关键词：
miR-155; mTOR; breast cancer; miRNA; Estrogen receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 43 条
  • [11] A phase II study of oral mammalian target of rapamycin (mTOR) inhibitor, RAD001 (everolimus), in patients with recurrent endometrial carcinoma (EC)
    Slomovitz, B. M.
    Lu, K. H.
    Johnston, T.
    Munsell, M.
    Ramondetta, L. M.
    Broaddus, R. R.
    Coleman, R. L.
    Walker, C.
    Gershenson, D. M.
    Burke, T. W.
    Wolf, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [12] Mammalian target of rapamycin inhibitor RAD001 sensitizes endometrial cancer cells to paclitaxel-induced apoptosis via the induction of autophagy
    Wang, Huan
    Li, Dandan
    Li, Xiaomao
    Ou, Xueling
    Liu, Suiling
    Zhang, Yu
    Ding, Jie
    Xie, Bo
    ONCOLOGY LETTERS, 2016, 12 (06) : 5029 - 5035
  • [13] Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro
    Gorshtein, Alexander
    Rubinfeld, Hadara
    Kendler, Efrat
    Theodoropoulou, Marily
    Cerovac, Vesna
    Stalla, Guenter K.
    Cohen, Zvi R.
    Hadani, Moshe
    Shimon, Ilan
    ENDOCRINE-RELATED CANCER, 2009, 16 (03) : 1017 - 1027
  • [14] THE MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR RAD001 INHIBTS PROLIFERATION OF T- AND B-LYMPHOBLASTIC CELLS VIA CELL CYCLE ARREST
    Schult, C.
    Amoroso, F.
    Dahlhaus, M.
    Ruck, S.
    Lange, S.
    Buljubasic, F.
    Freund, M.
    Neri, L.
    Junghanss, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 252 - 252
  • [15] Schedule-dependent effects of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib in combination with the mammalian target of rapamycin (mTOR) inhibitor everolimus (RAD001)
    Di Cosimo, S
    Matar, P
    Rojo, F
    Guzman, M
    Rodriguez, S
    Jimenez, J
    Arribas, J
    Cognetti, F
    Lane, H
    Baselga, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 213S - 213S
  • [16] Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
    Kensei Tobinai
    Michinori Ogura
    Dai Maruyama
    Toshiki Uchida
    Naokuni Uike
    Ilseung Choi
    Kenichi Ishizawa
    Kuniaki Itoh
    Kiyoshi Ando
    Masafumi Taniwaki
    Naomi Shimada
    Ken Kobayashi
    International Journal of Hematology, 2010, 92 : 563 - 570
  • [17] Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
    Tobinai, Kensei
    Ogura, Michinori
    Maruyama, Dai
    Uchida, Toshiki
    Uike, Naokuni
    Choi, Ilseung
    Ishizawa, Kenichi
    Itoh, Kuniaki
    Ando, Kiyoshi
    Taniwaki, Masafumi
    Shimada, Naomi
    Kobayashi, Ken
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (04) : 563 - 570
  • [18] Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells
    Eva Juengel
    Johanna Engler
    Iyad Natsheh
    Jon Jones
    Ausra Mickuckyte
    Lukasz Hudak
    Dietger Jonas
    Roman A Blaheta
    BMC Cancer, 9
  • [19] Combining the receptor tyrosine kinase inhibitor AEE788 and the mammalian target of rapamycin (mTOR) inhibitor RAD001 strongly inhibits adhesion and growth of renal cell carcinoma cells
    Juengel, Eva
    Engler, Johanna
    Natsheh, Iyad
    Jones, Jon
    Mickuckyte, Ausra
    Hudak, Lukasz
    Jonas, Dietger
    Blaheta, Roman A.
    BMC CANCER, 2009, 9
  • [20] Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin
    Hudson, CC
    Liu, M
    Chiang, GG
    Otterness, DM
    Loomis, DC
    Kaper, F
    Giaccia, AJ
    Abraham, RT
    MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (20) : 7004 - 7014
12345